Humanwell Healthcare Group Co (600079.SS) Stock Price

Humanwell Healthcare Group Co Price

🇨🇳SSE·CLOSED
17.25CNY
Market closed
Today +/-
Today %

Humanwell Healthcare Group Co (600079.SS) Stock | ISIN CNE000000QW6. The current Humanwell Healthcare Group Co stock price is 17.25 CNY (2026). Revenue is 28.53 B CNY. Net income is 2.4 B CNY. The P/E ratio is 11.66. Market capitalization is 27.97 B CNY. Humanwell Healthcare Group Co operates in the Health sector.

Humanwell Healthcare Group Co stock price

Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Humanwell Healthcare Group Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Humanwell Healthcare Group Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Humanwell Healthcare Group Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Humanwell Healthcare Group Co Stock Price History
DateHumanwell Healthcare Group Co Price
Access this data via the Eulerpool API
Get Free API Key

Humanwell Healthcare Group Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
748 M CNY
126 M CNY
51 M CNY
Jan 1, 2006
759 M CNY
80 M CNY
103 M CNY
Jan 1, 2007
709 M CNY
78 M CNY
68 M CNY
Jan 1, 2008
1.02 B CNY
127 M CNY
78 M CNY
Jan 1, 2009
1.33 B CNY
179 M CNY
201 M CNY
Jan 1, 2010
2.21 B CNY
370 M CNY
216 M CNY
Jan 1, 2011
3.62 B CNY
543 M CNY
300 M CNY
Jan 1, 2012
5.32 B CNY
700 M CNY
406 M CNY
Jan 1, 2013
6.01 B CNY
880 M CNY
418 M CNY
Jan 1, 2014
7.05 B CNY
927 M CNY
452 M CNY
Jan 1, 2015
10.05 B CNY
1.05 B CNY
654 M CNY
Jan 1, 2016
12.33 B CNY
1.31 B CNY
810 M CNY
Jan 1, 2017
15.45 B CNY
1.93 B CNY
1.99 B CNY
Jan 1, 2018
18.63 B CNY
1.86 B CNY
-2.45 B CNY
Jan 1, 2019
21.81 B CNY
2.46 B CNY
784 M CNY

Humanwell Healthcare Group Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 1:52 PM
 
REVENUE (M CNY)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M CNY)
NET INCOME (M CNY)
NET INCOME GROWTH (%)
DIV. (CNY)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Humanwell Healthcare Group Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Humanwell Healthcare Group Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Humanwell Healthcare Group Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Humanwell Healthcare Group Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Humanwell Healthcare Group Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Humanwell Healthcare Group Co stock margins

The Humanwell Healthcare Group Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Humanwell Healthcare Group Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Humanwell Healthcare Group Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
39.04 %
16.84 %
6.82 %
Jan 1, 2006
37.29 %
10.54 %
13.57 %
Jan 1, 2007
44.71 %
11 %
9.59 %
Jan 1, 2008
46.68 %
12.4 %
7.62 %
Jan 1, 2009
51.95 %
13.46 %
15.11 %
Jan 1, 2010
44.99 %
16.78 %
9.8 %
Jan 1, 2011
39.24 %
15 %
8.29 %
Jan 1, 2012
37.8 %
13.17 %
7.64 %
Jan 1, 2013
41.4 %
14.64 %
6.96 %
Jan 1, 2014
41.18 %
13.15 %
6.41 %
Jan 1, 2015
36.19 %
10.44 %
6.5 %
Jan 1, 2016
36.77 %
10.61 %
6.57 %
Jan 1, 2017
38.04 %
12.51 %
12.88 %
Jan 1, 2018
39.88 %
10 %
-13.12 %
Jan 1, 2019
39.49 %
11.26 %
3.6 %

Humanwell Healthcare Group Co Stock Revenue, EBIT, Earnings per Share

The Humanwell Healthcare Group Co earnings per share therefore indicates how much revenue Humanwell Healthcare Group Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2005
1.13 CNY
0.19 CNY
0.08 CNY
Jan 1, 2006
0.98 CNY
0.1 CNY
0.13 CNY
Jan 1, 2007
0.91 CNY
0.1 CNY
0.09 CNY
Jan 1, 2008
1.32 CNY
0.16 CNY
0.1 CNY
Jan 1, 2009
1.6 CNY
0.21 CNY
0.24 CNY
Jan 1, 2010
2.34 CNY
0.39 CNY
0.23 CNY
Jan 1, 2011
3.75 CNY
0.56 CNY
0.31 CNY
Jan 1, 2012
5.39 CNY
0.71 CNY
0.41 CNY
Jan 1, 2013
5.95 CNY
0.87 CNY
0.41 CNY
Jan 1, 2014
6.67 CNY
0.88 CNY
0.43 CNY
Jan 1, 2015
7.82 CNY
0.82 CNY
0.51 CNY
Jan 1, 2016
9.59 CNY
1.02 CNY
0.63 CNY
Jan 1, 2017
11.88 CNY
1.49 CNY
1.53 CNY
Jan 1, 2018
13.79 CNY
1.38 CNY
-1.81 CNY
Jan 1, 2019
16.14 CNY
1.82 CNY
0.58 CNY

Humanwell Healthcare Group Co business model & stock analysis

Humanwell Healthcare (Group) Co., Ltd. engages in the research and development, production, and sale of medical products. The company is headquartered in Wuhan, Hubei and currently employs 16,070 full-time employees. The Company’s products are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines and others. The firm also provides medical instruments. The firm distributes its products in both domestic market and to overseas markets.

Humanwell Healthcare Group Co Eulerpool Fair Value

Humanwell Healthcare Group Co historical P/E ratio, EBIT multiple, and P/S ratio

Humanwell Healthcare Group Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Humanwell Healthcare Group Co shares outstanding

The number of shares was Humanwell Healthcare Group Co in 2025 — This indicates how many shares 1.622 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2005
662 M base_Shares
Jan 1, 2006
778 M base_Shares
Jan 1, 2007
778 M base_Shares
Jan 1, 2008
778 M base_Shares
Jan 1, 2009
833 M base_Shares
Jan 1, 2010
943 M base_Shares
Jan 1, 2011
965 M base_Shares
Jan 1, 2012
987 M base_Shares
Jan 1, 2013
1.01 B base_Shares
Jan 1, 2014
1.06 B base_Shares
Jan 1, 2015
1.29 B base_Shares
Jan 1, 2016
1.29 B base_Shares
Jan 1, 2017
1.3 B base_Shares
Jan 1, 2018
1.35 B base_Shares
Jan 1, 2019
1.35 B base_Shares

Humanwell Healthcare Group Co Dividend History

27 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.32CNY↓ 47.5%1×
Aug 19, 20250.32CNY↑ 113.3%1/1
20240.61CNY↑ 281.2%2×
20230.16CNY↑ 6.7%1×
20220.15CNY↑ 50.0%1×
20210.1CNY↑ 100.0%1×
20200.05CNY↓ 68.8%1×
20180.16CNY↑ 45.5%1×
20170.11CNY↑ 10.0%1×
20160.1CNY↑ 33.3%1×
20150.08CNY↓ 37.5%1×

Humanwell Healthcare Group Co dividend history and estimates

In 2025, Humanwell Healthcare Group Co paid a dividend amounting to 0.32 CNY. Dividend means that Humanwell Healthcare Group Co distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2005
0.02 CNY
0 CNY
Jan 1, 2006
0.03 CNY
0 CNY
Jan 1, 2007
0.01 CNY
0 CNY
Jan 1, 2008
0.02 CNY
0 CNY
Jan 1, 2009
0.04 CNY
0 CNY
Jan 1, 2010
0.04 CNY
0 CNY
Invalid Date
0.04 CNY
0 CNY
Invalid Date
0.07 CNY
0 CNY
Invalid Date
0.1 CNY
0 CNY
Invalid Date
0.12 CNY
0 CNY
Invalid Date
0.08 CNY
0.08 CNY
Invalid Date
0.1 CNY
0.1 CNY
Jan 1, 2017
0.11 CNY
0 CNY
Jan 1, 2018
0.16 CNY
0 CNY
Jan 1, 2020
0.05 CNY
0 CNY

Humanwell Healthcare Group Co dividend payout ratio

In 2025, Humanwell Healthcare Group Co had a payout ratio of 9.83%. The payout ratio indicates the percentage of the company's profits that Humanwell Healthcare Group Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2005
8.38 %
Jan 1, 2006
7.69 %
Jan 1, 2007
4.44 %
Jan 1, 2008
7.5 %
Jan 1, 2009
8.75 %
Jan 1, 2010
8.7 %
Jan 1, 2011
6.45 %
Jan 1, 2012
8.54 %
Jan 1, 2013
12.2 %
Jan 1, 2014
13.95 %
Jan 1, 2015
14.71 %
Jan 1, 2016
15.87 %
Jan 1, 2017
7.19 %
Jan 1, 2018
-8.84 %
Jan 1, 2019
9.32 %
Price targets and forecasts for Humanwell Healthcare Group Co are not yet available.

EESG©

Eulerpool ESG Scorecard© for the Humanwell Healthcare Group Co stock

62/100
79
Environment
44
Social
64
Governance
E

Environment

20
Scope 1 - Direct Emissions19,500
Scope 2 - Indirect emissions from purchased energy106,000
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions125,500
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees43.722
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Humanwell Healthcare Group Co shareholder structure

% Name
23.85038%
WuHanDangDai Science & Technology Industries Group Co., Ltd.
WuHanDangDai Science & Technology Industries Group Co., Ltd.
5.34935%
Li (Jie)
Li (Jie)
3.68945%
Wuhu Xinfu Equity Investment Partnership LP
Wuhu Xinfu Equity Investment Partnership LP
2.65164%
Chen (Xiaoqing)
Chen (Xiaoqing)
1.66132%
Guotai Asset Management Co., Ltd.
Guotai Asset Management Co., Ltd.
1.61486%
Wuhan Hi-Tech State Holding Group Co., Ltd.
Wuhan Hi-Tech State Holding Group Co., Ltd.
1.44743%
Penghua Fund Management Co., Ltd.
Penghua Fund Management Co., Ltd.
1.15847%
INVESCO Great Wall Fund Management Co. Ltd.
INVESCO Great Wall Fund Management Co. Ltd.
1.11258%
Zhong Ou Asset Management Co., Ltd.
Zhong Ou Asset Management Co., Ltd.
1.04375%
Ping An Anying Equity Pension Products
Ping An Anying Equity Pension Products
...

Humanwell Healthcare Group Co Executives and Management Board

XD

Mr. Xiafei Deng

(60)

President, Acting Secretary of the Board, Director · since 1998

Compensation7.19 M CNY
JL

Mr. Jie Li

(68)

Director · since 2003

Compensation5.67 M CNY
HZ

Mr. Hongjie Zhang

(59)

Vice President

Compensation4.97 M CNY
WD

Mr. Wentao Du

(56)

Vice President

Compensation4.07 M CNY
LL

Ms. Li'e Li

(58)

Vice President, Chief Engineer

Compensation3.7 M CNY

Humanwell Healthcare Group Co Supply Chain

Frequently asked questions about Humanwell Healthcare Group Co

All fundamentals and in-depth analysis of Humanwell Healthcare Group Co

Our stock analysis for Humanwell Healthcare Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humanwell Healthcare Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co Revenue→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co Net Income→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co P/E→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co P/S→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co EBIT→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co Dividend→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co Directors Dealings→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co Stocks→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co Market capitalization→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co Debt→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co Liabilities→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co Equity→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co AAQS→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co Employees→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co ROE→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co ROA→
Humanwell Healthcare Group Co Stock
Humanwell Healthcare Group Co ROCE→